ArticleBMC infectious diseases2025
The potential of genome-oriented blood culture surveillance of vancomycin-resistant enterococcus faecium (VRE) to mirror local VRE epidemiology: a retrospective analysis and systematic comparison of VRE blood culture and VRE first patient isolates.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate whether vancomycin-resistant Enterococcus faecium (VRE) blood culture isolates reflect the broader hospital VRE epidemiology and to investigate the population structure of VRE in the context of rising bloodstream infection (BSI) rates at our institution.
methodsWhole genome sequencing (WGS) of VRE BSI isolates and all VRE first annual patient isolates (screening and clinical specimens) at a university tertiary care hospital from 2018 to 2021 was performed. Isolates were analysed using multi-locus sequence typing (MLST), core-genome (cg) MLST, and cluster analysis based on pairwise allelic differences.
resultsFrom 2018 to 2021, 128 patients had VRE BSI and 218 had VSE (vancomycin-susceptible Enterococcus faecium) BSI, however, VRE became dominant in 2021 (2018: 53 vs. 21; 2021: 42 vs. 48). Concurrently, VRE incidence at our institution rose from 2.7 to 4.3 per 1000 patient days. WGS was performed for 125/128 VRE BSI isolates (97.7%) and 1175/1534 first annual isolates (76.6%). Distribution of complex types (CTs) within VRE blood culture isolates and first annual isolates was generally similar: ST80/CT1065, ST117/CT5130, ST1299/CT1903 and ST117/CT71 were detected most often both in BSI and among first annual isolates (26.5% vs. 26.6%; 14.4% vs. 10.8%; 12.0% vs. 13.5%; 10.4% vs. 13.3%, respectively). Eleven large clusters comprising 10 or more isolates were identified within the representative isolate cohort (a curated dataset including all sequenced blood culture isolates and non-redundant first annual patient isolates), consistent with clonal expansion of successful lineages, likely driven at least in part by in-hospital transmission events, but also possibly by repeated introductions of circulating clones, contributing to the rise in VRE incidence.
conclusionsPerforming WGS on both VRE blood culture and first annual isolates points to several outbreaks as the reason behind the increase in VRE BSI rate. Our results demonstrate that sequencing VRE blood culture isolates alone roughly reflects the distribution of all VRE CTs, making it a pragmatic and resource-efficient approach for obtaining valuable information about the epidemiology of VRE within a hospital. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.